SCHEMBL29324065

SCHEMBL29324065

COC(=O)c1ccc(-c2cnccn2)c2c1NC(=O)CO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
HTT P42858 2/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 2/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
MAP2K1 Q02750 1/20 0.34
CYP46A1 Q9Y6A2 1/20 0.34
AXL P30530 2/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PIK3CA P42336 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
ROCK2 O75116 2/20 0.32
CCNC P24863 2/20 0.32
CDK8 P49336 2/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31056909 1.00 KDM4E (0.35) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29323704 0.83 KDM4E (0.36) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL31056919 0.78 KDM4E (0.40) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29321031 0.78 KDM4E (0.40) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29323699 0.75 KDM4E (0.38) KDM4EGLAGAA
SCHEMBL11296276 0.72 KDM4E (0.51) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29279278 0.71 KMT2A (0.55) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL30336285 0.71 KMT2A (0.55) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL16277802 0.70 CYP46A1 (0.66) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL22460281 0.70 KDM4E (0.43) KDM4EHTTHSD17B10ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed